HIV and hepatitis C virus (HCV) have both been associated with cognitive impairment. Combination antiretroviral therapy (cART) has dramatically changed the nature of cognitive impairment in HIV-infected persons, while the role of direct-acting antivirals (DAA) in neurocognition of HCV-infected individuals remains unclear. Also, whether HIV and HCV interact to promote neurocognitive decline or whether they each contribute an individual effect continues to be an open question. In this work, we review the virally mediated mechanisms of HIV- and HCV-mediated neuropathogenesis, with an emphasis on the role of dual infection, and discuss observed changes with HIV viral suppression and HCV functional cure on neurocognitive impairments.
CITATION STYLE
Abutaleb, A., Kattakuzhy, S., Kottilil, S., O’Connor, E., & Wilson, E. (2018, December 1). Mechanisms of neuropathogenesis in HIV and HCV: similarities, differences, and unknowns. Journal of NeuroVirology. Springer. https://doi.org/10.1007/s13365-018-0678-5
Mendeley helps you to discover research relevant for your work.